Fulgent Genetics Inc logo

Fulgent Genetics Inc Investor Relations Material

Fulgent Genetics, Inc. provides clinical genetic testing services in the United States and internationally. It offers genetic testing services for various types of heredity conditions, such as intellectual disability and movement disorders; infectious diseases, including sexually transmitted infections; pharmacogenetic tests to help individuals determine drug sensitivities; oncology testing services focused on inherited cancer predisposition; prenatal genetic testing for genetic abnormalities; and pediatric and adult behavioral tests for attention deficit hyperactivity disorders. The company also provides COVID-19 testing kits to physicians. In addition, it offers development of customized multi-gene panels for clinical trial recruitment, which are designed for specific panels of genes associated with various genotypes or phenotypes; and PathFinderTG tool that evaluates the likelihood that a patient's symptoms could be caused by an underlying genetic condition. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California

Latest company events

Ticker symbol



United States of America

Investor Relations Page


Dig deeper into the Fulgent Genetics Inc fundamentals on Quartr.

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
App store link
Android play link
Quartr app screenshot